SurModics
SRDX
$34.26
Share price
33.38%
Change (1 day)
49.04%
Change (1 year)
Categories
P/S ratio for SurModics (SRDX)
P/S ratio as of May 2024 (TTM): 2.65
According to SurModics's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 2.64627. At the end of 2023 the company had a P/S ratio of 3.74.
P/S ratio history for SurModics from 2001 to 2023
PS ratio at the end of each year
| Year | P/S ratio | Change |
|---|---|---|
| 2023 | 3.74 | -20.86% |
| 2022 | 4.73 | -25.59% |
| 2021 | 6.36 | 0.95% |
| 2020 | 6.30 | 12.34% |
| 2019 | 5.61 | -23.83% |
| 2018 | 7.36 | 44.16% |
| 2017 | 5.11 | 10% |
| 2016 | 4.64 | 13.19% |
| 2015 | 4.10 | -17.15% |
| 2014 | 4.95 | -16.32% |
| 2013 | 5.92 | -2.81% |
| 2012 | 6.09 | 31.23% |
| 2011 | 4.64 | 45.31% |
| 2010 | 3.19 | -38.98% |
| 2009 | 5.23 | 59.85% |
| 2008 | 3.27 | -73.52% |
| 2007 | 12.4 | 51.46% |
| 2006 | 8.16 | -22.98% |
| 2005 | 10.6 | -4.32% |
| 2004 | 11.1 | 26.23% |
| 2003 | 8.77 | -44.35% |
| 2002 | 15.8 | -38.09% |
| 2001 | 25.5 |
P/S ratio for similar companies or competitors
| Company | P/S ratio | P/S ratio differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | 3.75 | 41.55% | 🇺🇸 USA |
 Abbott Laboratories ABT | 4.58 | 73.24% | 🇺🇸 USA |
 Thermo Fisher Scientific TMO | 5.07 | 91.42% | 🇺🇸 USA |
 Agilent Technologies A | 5.96 | 125.33% | 🇺🇸 USA |
 PerkinElmer
PKI | 4.31 | 62.70% | 🇺🇸 USA |
 Alkermes ALKS | 2.50 | -5.68% | 🇮🇪 Ireland |
 Nektar Therapeutics
NKTR | 2.97 | 12.41% | 🇺🇸 USA |
 Heron Therapeutics HRTX | 2.75 | 3.74% | 🇺🇸 USA |
 Enzo Biochem ENZ | 4.16 | 57.21% | 🇺🇸 USA |